EPCT-02. PBTC-051: FIRST IN PEDIATRICS PHASE 1 STUDY OF CD40 AGONISTIC MONOCLONAL ANTIBODY APX005M IN PEDIATRIC SUBJECTS WITH RECURRENT/REFRACTORY BRAIN TUMORS

BACKGROUND: CD40 is a co-stimulatory molecule expressed on antigen presenting cells (APCs). APX005M is a CD40 agonist monoclonal antibody which stimulates innate and adaptive anti-tumor immunity through activation of APCs, macrophages, and antigen-specific CD8(+)T-cells. Pediatric Brain Tumor Consor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindsay, Holly, Onar-Thomas, Arzu, Kocak, Mehmet, Poussaint, Tina Young, Dhall, Girish, Broniscer, Alberto, Vinitsky, Anna, MacDonald, Tobey, Trifan, Ovid, Fangusaro, Jason, Dunkel, Ira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Early Phase Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715375/
http://dx.doi.org/10.1093/neuonc/noaa222.127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715375/
http://dx.doi.org/10.1093/neuonc/noaa222.127

Ejemplares similares